Exciting News: The Final Issue of the BioBinding Bulletin for 2024 is Here! As we wrap up another incredible year, we're thrilled to announce the release of the December issue of the BioBinding Bulletin. This edition is a special feature with our top story: the science behind the beloved seasonal tradition of mulled wine! As we look back on 2024, we want to express our heartfelt gratitude to our readers, contributors, and partners. Your support and engagement have been invaluable, and we look forward to continuing this journey together in the coming year. 🎄 Season's Greetings and Best Wishes for a Joyful and Prosperous New Year! 🎄 May your holidays be filled with warmth, happiness, and a touch of scientific wonder. Here's to a bright and exciting 2025! #OctetBLI #OctetSPR #BioBindingBulletin #Science #Innovation #SeasonGreetings #MulledWine #Newsletter #2024Recap #HappyHolidays
Octet®- Affinity, Binding Kinetics and Concentration
Biotechnologieforschung
Goettingen, Niedersachsen 4.247 Follower:innen
Label-Free, Stress-Free Solutions for Drug Discovery and Biologics
Info
At this channel, we want to focus on label-free biomolecular interaction analysis such as protein-protein or protein-drug interactions. We will keep you updated on the newest developments and most exciting trends in the field, technical details and performance of our Octet® platform. We at Sartorius believe that listening to our customers, discussions with and among users are a key component to deliver innovative products that continually offer higher data quality to improve the outcomes of life science research and development projects. Furthermore, it helps us to understand the diverse landscape of laboratories on a global scale. Therefore, we would highly encourage you to engage with us in lively discussions. Therapeutic proteins, monoclonal antibodies (mAbs), bispecific antibodies (bsAbs), and antibody-drug conjugates (ADCs) are all large complex molecules that require reliable in-depth binding characterization and robust concentration determination of active analyte or impurities such as host cell protein (HCP). On the other hand, screening and characterizing small drug molecules is equally important. Octet® instruments eliminate many of the common issues associated with detailed characterization of binding and functional activities. The platform leverages proprietary Bio Layer Interferometry (BLI) technology, which uses optical biosensors to measure molecular interactions in parallel, without the use of detection agents. This robust and fluidics-free approach for direct measurement even in complex mixtures and unpurified samples enables an enviable variety of applications throughout biologics development from early selection to validation to manufacturing to QC. It is a precise and efficient means of collecting a wide range of information related to affinity, binding kinetics, analyte concentration, bio-similarity, specificity, potency, and selectivity of molecular binding. Follow us today to stay updated. The path to progress just got simpler.
- Website
-
https://www.sartorius.com/en/applications/life-science-research/label-free-detection
Externer Link zu Octet®- Affinity, Binding Kinetics and Concentration
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Goettingen, Niedersachsen
- Spezialgebiete
- BioLayer Interferometry, Biomolecular Interaction Analysis, Binding Kinetics, Analytical Instrumentation, Affinity Assays, Concentration Assays, Antibody Quantitation, Protein Quantitation, Protein Characterization, Analyze Therapeutic Molecules, Large Molecule Research, Biophysical Characterization, Receptor-Ligand Binding, Titer Determination, Fragment Screening, Potency Assays, Host Cell Protein Detection, Residual Protein A Detection, Bioprocess Impurity Testing und IgG Titer
Updates
-
Currently, there is a need for N-terminal amino acid binders (NAABs) that can selectively identify amino acids at the N-terminus of a peptide. Researchers from IBBR Institute for Bioscience and Biotechnology Research identified sequence variants of human protein GID4 with increased binding to N-terminal proline (Nt-Pro). Read here: https://ow.ly/x73P50Ulxvh National Institute of Standards & Industrial Technology (NISIT) University of Maryland #OctetBLI #kinetics #biotechnology #ProteinSquencing #DirectedEvolution
-
Researchers from Scripps Research demonstrate a novel AI-driven approach that can predict the conformational landscape of complex pathogens. This framework can be used to stabilize viral proteins, such as LASV GPC, in their prefusion conformation, optimizing them for stability and expression, and offering a streamlined framework for vaccine design and broader applications in viral immunogen engineering. Read the publication: https://ow.ly/KXAx50UlxrK #OctetBLI #LassaVirus #immunology #VaccineResearch #glycoprotein #NeutralizingAntibodies
-
Transform Your AAV Empty/Full Ratio Workflow ◼️ Efficient: complete assay in as little as 30 minutes ◼️ Suitable for analysis of crude and purified AAV samples ◼️ No sample purification or enzymatic digestion required (analyzes intact viral capsids) ◼️ Compatible with multiple AAV serotypes ◼️ Cost-effective: Octet®️ AAVX Biosensors can be regenerated and re-used multiple times ◼️ Ideal for screening applications in upstream and downstream process development Direct download article: https://ow.ly/hMqZ50U9Pfu #OctetBLI #AdenoAssociatedVirus #AAV #GeneTherapy #Bioprocessing #AAV #ViralVector #BiotechInnovation #biopharma
-
Meet Octet®️ ARC Biosensors for rapid, high-throughput kinetic and quantitation analysis of rabbit IgG antibodies. With high specificity, high ligand loading capacity, and a wide quantitation dynamic range, the new biosensors are a reliable and versatile tool for characterizing rabbit IgG in crude and purified samples across both upstream and downstream bioprocessing workflows. Learn more: https://ow.ly/aCkv50TNikS #OctetBLI #biopharma #kinetics #antibody #CellLineDevelopment #bioproduction #QCtesting
-
Octet®️ BLI Discovery and Analysis Studio Software are powerful tools designed to simplify data acquisition and analysis for label-free biomolecular interaction studies using the genuine BLI platform. In this collection of tutorial videos, we will explore the key features and functionalities of both software packages, providing you with the knowledge to master these tools and streamline your biomolecular interaction analysis workflow. Watch our tutorials here: https://ow.ly/H8gm50U9OP6 #OctetBLI #bioanalysis #kinetics #protein #Biopharma #ReceptorBinding
-
The journey to perfecting Chimeric Antigen Receptor (CAR) constructs for CAR-T cell therapy is filled with challenges, especially in achieving precise specificity for target antigens. These hurdles can lead to tumor resistance, unwanted effects, and toxicities. Enter advanced optical biosensing technology! Biolayer Interferometry (BLI) is advancing the field by offering real-time, label-free analysis of biomolecular interactions. This cutting-edge technology provides crucial insights into binding kinetics and affinities, all without altering the biomolecules. Discover how the Octet® BLI system is paving the way for innovative CAR construct creation and testing in both research and clinical settings in our latest article. Article highlights: ◼️ Challenges in CAR development ◼️ Strategies for fine-tuning specificity to minimize side effects ◼️ Tips for addressing high and low antigen densities ◼️ Approaches for targeting solid tumors with low antigen density Learn more: https://ow.ly/bTF350U92vL #OctetBLI #CellTherapy #CancerResearch #Sartorius #BiolayerInterferometry #OncologyResearch #Biotechnology
-
Researchers from The Johns Hopkins University present a roadmap for the design and translation of cytokine/antibody fusion proteins. They optimized immunocytokines (IC) construction and engineered the cytokine/antibody affinity to improve immune bias. Their findings demonstrate that their IC preferentially activates and expands immune effector cells, leading to superior antitumor activity without inducing toxicity. Learn more: https://ow.ly/ZiIg50U4hQz #OctetBLI #immunology #CancerResearch #antibody #immunocytokines National Institutes of Health Emory University Institute of Biotechnology Charles University
-
Issue 11 of 'BioBinding Bulletin' is out now! This edition emphasizes the latest advancements in AAV capsid quantification. 🔬 Key Highlights: ☑ Streamlined AAV Titer Determination: Simplify your workflow with real-time data in just 15 minutes using the Octet® AAVX Biosensors. ☑ Innovative Empty/Full Capsid Ratio Analysis: Analyze intact viral capsids without the need for sample purification or enzymatic digestion in additional 30 min. ☑ Efficiency and Flexibility: Ideal for screening applications in both upstream and downstream bioprocessing stages, suitable for both crude and purified AAV samples. It also highlights the Octet® Publication Search Tool and upcoming events. Don't forget to subscribe for future issues and join the conversation by sharing your thoughts and insights in the comments section. Happy reading! #GeneTherapy #BioanalyticalMethods #Bioprocessing #AAV #Biotechnology #Innovation #Sartorius #BioBindingBulletin #OctetBLI #AAVX #CapsidQuantification #BiolayerInterferometry #ScientificResearch #BiotechNews
Issue 11 - Breakthroughs in AAV Development: The Evolution of Biosensor-Based Applications in Gene Therapy
Octet®- Affinity, Binding Kinetics and Concentration auf LinkedIn
-
What role do Fcγ receptors play in regulating immune responses, and how can this knowledge be applied to assay design? To explore this, we offer detailed guidelines for optimizing assay performance and designing effective assays to analyze the binding kinetics and affinities of IgG1, IgG2, and IgG4 antibodies with Fcγ receptors. Download our application note to learn more: https://ow.ly/oarO50TZe1m #OctetBLI #antibody #kinetics #AssayDesign #ReceptorBinding #Biopharma